Announcements Trials
Browse Landscape

Status

Completed 1

Sponsor Class

OTHER 4INDUSTRY 2NETWORK 1

Study Type

Interventional 8Observational 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1

Conditions

Leukemia, Lymphocytic, Chronic, B-Cell 1

Interventions

Gene Expression Profiling 74Polymerase Chain Reaction 44Microarray Analysis 40Amplified Fragment Length Polymorphism Analysis 37Immunohistochemistry 35Flow Cytometry 30Reverse Transcriptase Polymerase Chain Reaction 22DNA Methylation 16Blotting, Western 15Cytogenetic Analysis 14Base Sequence 12Psychiatric Rehabilitation 11In Situ Hybridization, Fluorescence 10Immunologic Techniques 9Enzyme-Linked Immunosorbent Assay 7Mental Status and Dementia Tests 6Comparative Genomic Hybridization 6Watchful Waiting 5Specimen Handling 5Pharmacogenomic Testing 5Mass Spectrometry 5Gene Rearrangement 5Chromosome Mapping 5Surveys and Questionnaires 4Surgical Procedures, Operative 4Rituximab 4Paclitaxel 4Interviews as Topic 4In Situ Hybridization 4Immunoenzyme Techniques 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NETWORK × Observational × Bendamustine Hydrochloride × Clear all
NCT02381899 2019-02-01

Observational Study in CLL Patients Receiving BR

Czech CLL Study Group

Completed
83 enrolled
LymphoidOther hematologic neoplasm

Leukemia, Lymphocytic, Chronic, B-Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡